- Home
- GOVX vs YCBD Comparison
GOVX vs YCBD Comparison
Compare GOVX & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOVX | YCBD |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | United States | United States |
| Employees | 19 | 42 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 7.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GOVX | YCBD |
|---|---|---|
| Price | $1.00 | $0.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.00 | ★ $2.00 |
| AVG Volume (30 Days) | ★ 306.3K | 193.3K |
| Earning Date | 04-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.70 |
| Revenue Next Year | N/A | $7.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.48 |
| 52 Week High | $4.40 | $2.56 |
Technical Indicators
Market Signals| Indicator | GOVX | YCBD |
|---|---|---|
| Relative Strength Index (RSI) | 38.09 | 35.00 |
| Support Level | $0.96 | $0.48 |
| Resistance Level | $2.00 | $0.84 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 35.22 | 10.93 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.